Archives of Oral Biology
Volume 55, Issue 5 , Pages 333-342 , May 2010

ACh- and VIP-induced vasorelaxation in rabbit facial artery after carotid artery occlusion

  • Jelena Roganović

      Affiliations

    • Department of Pharmacology, Faculty of Stomatology, University of Belgrade, Belgrade, Serbia
    • ,
  • Miroslav Radenković

      Affiliations

    • Department of Clinical Pharmacology, Pharmacology and Toxicology, Medical Faculty, University of Belgrade, Belgrade, Serbia
    • ,
  • Dragica Stojić

      Affiliations

    • Department of Pharmacology, Faculty of Stomatology, University of Belgrade, Belgrade, Serbia
    • Corresponding Author InformationCorresponding author at: Department of Pharmacology, Faculty of Stomatology, University of Belgrade, Dr Subotića 1, 11000 Belgrade, Serbia. Tel.: +381 112682373; fax: +381 112685361.

,Accepted 10 March 2010.

References 

  1. Michiels C. Physiological and pathological responses to hypoxia. Am J Pathol. 2004;164:1875–1882
  2. Vág J, Hably C, Kerémi B, Kovács E, Bartha J, Fazekas Á. Role of nitric oxide in the regulation of blood flow in the rat submandibular gland during carotid artery occlusion. Arch Oral Biol. 2001;46:261–267
  3. Suarez-Cunqueiro MM, Duker J, Liebehenschel N, Shon R, Schmelzeisen R. Calcification of the branches of the external carotid artery detected by panoramic radiography: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94:636–640
  4. Widlansky ME, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149–1160
  5. Ruijtenbeek K, Kessels CG, Villamor E, Blanco CE, De Mey JG. Direct effects of acute hypoxia on the reactivity of peripheral arteries of the chicken embryo. Am J Physiol Regul Integr Comp Physiol. 2002;283:R331–R338
  6. Juranek I, Bauer V, Donnerer J, Lembeck F, Peskar BA. Severe hypoxia inhibits prostaglandin I(2) biosynthesis and vasodilatory responses induced by ionophore A23187 in the isolated rabbit ear. Pharmacology. 2002;66:199–205
  7. Sobey CG. Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol. 2001;21:28–38
  8. Semenza GL. New insights into nNOS regulation of vascular homeostasis. J Clin Invest. 2005;115:2976–2978
  9. Corbucci GG, Marchi A, Lettieri B, Luongo C. Mechanisms of cell protection by adaptation to chronic and acute hypoxia: molecular biology and clinical practice. Minerva Anestesiol. 2005;71:727–740
  10. Stojić D, Radenković M, Kršljak E, Popović J, Pešić S, Grbović L. Influence of the endothelium on the vasorelaxant response to acetylcholine and vasoactive intestinal polypeptide in the rabbit facial artery. Eur J Oral Sci. 2003;111:137–143
  11. Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L. Ischemia–reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J. 2003;17:2328–2330
  12. Fernández N, Martínez MA, Climent B, García-Villalón AL, Monge L, Sanz E, et al. In vivo coronary effects of endothelin-1 after ischemia–reperfusion. Role of nitric oxide and prostanoids. Eur J Pharmacol. 2003;481:109–117
  13. Radovits T, Zotkina J, Lin LN, Karck M, Szabó G. Endothelial dysfunction after hypoxia–reoxygenation: do in vitro models work?. Vascul Pharmacol. 2009;51:37–43
  14. Meeking DR, Browne DL, Allard S, Munday J, Chowienczyck PJ, Shaw KM, et al. Effects of cyclo-oxygenase inhibition on vasodilatory response to acetylcholine in patients with type 1 diabetes and nondiabetic subjects. Diabetes Care. 2000;23:1840–1843
  15. Nacci C, Tarquinio M, De Benedictis L, Mauro A, Zigrino A, Carratù MR, et al. Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. Endocrinology. 2009;150(2):849–861
  16. Chenevard R, Hürlimann D, Béchir M, Enseleit F, Spieker L, Hermann M, et al. Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation. 2003;107(3):405–409
  17. Widlansky ME, Price DT, Gokce N, Eberhardt RT, Duffy SJ, Holbrook M, et al. Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension. Hypertension. 2003;42(3):310–315
  18. Davidge ST. Prostaglandin H synthase and vascular function. Circ Res. 2001;89:650–660
  19. Najibi S, Cowan CL, Palacino JJ, Cohen RA. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol. 1994;266:H2061–H2067
  20. Nishikawa Y, Stepp DW, Chilian WM. Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol. 2000;279:H459–H465
  21. Nagao T, Illiano S, Vanhoutte PM. Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-l-arginine in rats. Am J Physiol. 1992;263:H1090–H1094
  22. Abu-Soud HM, Rousseau DL, Stuehr DJ. Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension. J Biol Chem. 1996;271(51):32515–32518
  23. Prabhakar NR, Pieramici SF, Premkumar DR, Kumar GK, Kalaria RN. Activation of nitric oxide synthase gene expression by hypoxia in central and peripheral neurons. Brain Res Mol Brain Res. 1996;43(1–2):341–346
  24. Stuehr DJ, Santolini J, Wang ZQ, Wei CC, Adak S. Update on mechanism and catalytic regulation in the NO synthases. J Biol Chem. 2004;279:36167–36170
  25. Toda N, Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol Rev. 2003;55(2):271–324
  26. Buchwalow IB, Podzuweit T, Bocker W, Samoilova VE, Thomas S, Wellner M, et al. Vascular smooth muscle and nitric oxide synthase. FASEB J. 2002;16(6):500–508
  27. Stanarius A, Seidel B, Wolf G. Neuronal nitric oxide synthase in the vasculature of the rat brain: immunocytochemical study using the tyramide signal amplification technique. J Neurocytol. 1998;27:731–736
  28. Loesch A, Burnstock G. Perivascular nerve fibres and endothelial cells of the rat basilar artery: immuno-gold labeling of antigenic sites for type I and type III nitric oxide synthase. J Neurocytol. 1998;27:197–204
  29. Ben-Haim G, Armstead WM. Role of cAMP and K(+) channel-dependent mechanisms in piglet hypoxic/ischemic impaired nociceptin/orphanin FQ-induced cerebrovasodilation. Brain Res. 2000;884:51–58
  30. Hayashi S, Morishita R, Nakamura S, Yamamoto K, Moriguchi A, Nagano T, et al. Potential role of hepatocyte growth factor, a novel angiogenic growth factor, in peripheral arterial disease: downregulation of HGF in response to hypoxia in vascular cells. Circulation. 1999;100(19 Suppl.):II301–II308
  31. Tanaka K, Nogawa S, Nagata E, Suzuki S, Dembo T, Kosakai A, et al. Inhibition of cyclic AMP-dependent protein kinase in the acute phase of focal cerebral ischemia in the rat. Neuroscience. 1999;94:361–371
  32. Edwards AV. Autonomic control of salivary blood flow. In:  Garrett JR,  Ekström J,  Anderson LC editor. Glandular mechanisms of salivary secretion. Frontiers of oral biology. vol. 10:Basel: Karger; 1998;
  33. Lundberg JM, Änggård A, Fahrenkrug J. Complementary role of vasoactive intestinal polypeptide (VIP) and acetylcholine for cat submandibular blood flow and secretion. Acta Physiol Scand. 1982;114:329–337
  34. Modin A, Weitzberg E, Lundberg JM. Nitric oxide regulates peptide release from parasympathetic nerves and vascular reactivity to vasoactive intestinal peptide in vivo. Eur J Pharmacol. 1994;261:185–197
  35. Anderson LC, Garrett JR. Neural regulation of submandibular gland blood flow in the streptozotocin-diabetic rat: evidence for impaired endothelium-dependent vasodilatation. Arch Oral Biol. 2004;49:183–191
  36. Duncan IC, Spiro FI, van Staden D. Acute ischemic sialadenitis following facial artery embolization. Cardiovasc Intervent Radiol. 2004;27:300–302

PII: S0003-9969(10)00057-9

doi: 10.1016/j.archoralbio.2010.03.006

Archives of Oral Biology
Volume 55, Issue 5 , Pages 333-342 , May 2010

Article Tools

* Image Usage & Resolution